...
首页> 外文期刊>Tissue engineering, Part C. Methods >Improved Explant Method to Isolate Umbilical Cord-Derived Mesenchymal Stem Cells and Their Immunosuppressive Properties
【24h】

Improved Explant Method to Isolate Umbilical Cord-Derived Mesenchymal Stem Cells and Their Immunosuppressive Properties

机译:分离脐带间充质干细胞的改良外植体方法及其免疫抑制特性

获取原文
获取原文并翻译 | 示例
           

摘要

The umbilical cord (UC) has become one of the major sources of mesenchymal stem cells (MSCs). The common explant method of isolating UC-derived MSCs (UC-MSCs) involves mincing the UCs into small fragments, which are then attached to a culture dish bottom from which the MSCs migrate. However, the fragments frequently float up from the bottom of the dish, thereby reducing the cell recovery rate. To overcome this problem, we demonstrate an improved explant method for UC-MSC isolation, which involves the use of a stainless steel mesh (Cellamigo((R)); Tsubakimoto Chain Co.), to protect the tissue from floating after the minced fragments are aligned at regular intervals in culture dishes. The culture medium was refreshed every 3 days and the adherent cells and tissue fragments were harvested using trypsin. The number of UC-MSCs isolated from 1 g of UC using the explant method with Cellamigo was 2.9 +/- 1.4x10(6)/g, which was significantly higher than that obtained without Cellamigo (0.66 +/- 0.53x10(6)/g) (n=6, p<0.01) when cells reached 80-90% confluence. In addition, the processing and incubation time required to reach 80-90% confluence was reduced in the improved explant method compared with the conventional method. The UC-MSCs isolated using the improved method were positive for CD105, CD73, CD90, and HLA class I expression and negative for CD45 and HLA class II expression. The isolated UC-MSCs efficiently inhibited the responder T cells induced by allogeneic dendritic cells in a mixed lymphocyte reaction. Conclusively, we demonstrated that the use of Cellamigo improves the explant method for isolating UC-MSCs.
机译:脐带(UC)已成为间充质干细胞(MSC)的主要来源之一。分离来自UC的MSC(UC-MSC)的常用外植方法包括将UC切成小片段,然后将其附着到MSC迁移的培养皿底部。但是,碎片经常从培养皿的底部浮起,从而降低了细胞回收率。为了克服这个问题,我们证明了用于UC-MSC分离的改进的外植体方法,其涉及使用不锈钢网(Cellamigo(R);椿本链公司),以保护组织在切碎的碎片之后不漂浮。在培养皿中定期对齐。每三天刷新一次培养基,并使用胰蛋白酶收集粘附的细胞和组织片段。使用Cellamigo采用外植法从1 g UC中分离出的UC-MSC的数量为2.9 +/- 1.4x10(6)/ g,显着高于没有Cellamigo的情况(0.66 +/- 0.53x10(6) / g)(n = 6,p <0.01)当细胞达到80-90%融合时。此外,与传统方法相比,改进的外植体方法减少了达到80-90%融合所需的处理和孵育时间。使用改进方法分离的UC-MSC对CD105,CD73,CD90和HLA I类表达呈阳性,而对CD45和HLA II类表达呈阴性。分离的UC-MSC在混合淋巴细胞反应中有效抑制了同种树突状细胞诱导的应答性T细胞。最终,我们证明了Cellamigo的使用改善了用于分离UC-MSC的外植体方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号